Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors October 16, 2023
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock September 18, 2023
UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc. December 12, 2022
